 |
(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes |
| EU Market Approval | EU |
| EU Designation Date | 2015-08-10 00:00:00 |
| Sponsor | Khondrion BV |
